R Mick
Overview
Explore the profile of R Mick including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
129
Citations
1556
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Dai C, Furth E, Mick R, Koh J, Takayama T, Niitsu Y, et al.
Gastroenterology
. 2000 Oct;
119(4):929-42.
PMID: 11040180
Background & Aims: p16(INK4a) is a cell cycle inhibitor and a major tumor-suppressor protein, but the regulation of p16(INK4a) is poorly understood and the physiologic settings in which it exerts...
12.
Cohen-Jonathan E, Muschel R, McKenna W, Evans S, Cerniglia G, Mick R, et al.
Radiat Res
. 2000 Aug;
154(2):125-32.
PMID: 10931682
Successful radiosensitization requires that tumor cells become more radiosensitive without causing an equivalent reduction in the survival of cells of the surrounding normal tissues. Since tumor cell radiosensitivity can be...
13.
Mick R, Crowley J, Carroll R
Control Clin Trials
. 2000 Jul;
21(4):343-59.
PMID: 10913809
Phase II evaluation is a critical screening step in the development of new cancer treatments. Historically, anticancer agents have been cytotoxic; they kill existing cells. As such, the primary endpoint...
14.
Mathias C, Mick R, Grupp S, Duffy K, Harris F, Laport G, et al.
J Hematother Stem Cell Res
. 2000 Jul;
9(3):393-400.
PMID: 10894361
When interleukin-2 (IL-2) binds to the IL-2 receptor (IL2-R) on activated T cells, a soluble portion of the receptor (sIL2-R) is released. After allogeneic bone marrow transplantation (BMT), the serum...
15.
Bedrosian I, Reynolds C, Mick R, Callans L, Grant C, Donohue J, et al.
Cancer
. 2000 Jun;
88(11):2540-5.
PMID: 10861431
Background: Patients with large breast tumors are increasingly undergoing neoadjuvant treatment to downstage local disease; however, accurate staging of the axilla before the initiation of chemotherapy remains problematic. In the...
16.
Bedrosian I, Faries M, Guerry 4th D, Elenitsas R, Schuchter L, Mick R, et al.
Ann Surg Oncol
. 2000 May;
7(4):262-7.
PMID: 10819365
Background: Patients with thin primary melanomas (< or = 1 mm) generally have an excellent prognosis. However, the presence of a vertical growth phase (VGP) adversely impacts the survival rate....
17.
Porter D, Collins Jr R, Hardy C, Kernan N, Drobyski W, Giralt S, et al.
Blood
. 2000 Feb;
95(4):1214-21.
PMID: 10666193
The efficacy and toxicity of donor leukocyte infusions (DLI) after unrelated donor bone marrow transplantation (BMT) is largely unknown. We identified 58 recipients of unrelated DLI (UDLI) for the treatment...
18.
Stadtmauer E, Tsai D, Sickles C, Mick R, Luger S, Porter D, et al.
Med Oncol
. 2000 Jan;
16(4):279-88.
PMID: 10618691
The purpose of this study was to determine the efficacy, engraftment kinetics, effect of bone marrow tumor contamination, and safety of high-dose therapy and granulocyte-colony stimulating factor (G-CSF) mobilized peripheral...
19.
Toyoizumi T, Mick R, Abbas A, Kang E, Kaiser L, Molnar-Kimber K
Hum Gene Ther
. 1999 Dec;
10(18):3013-29.
PMID: 10609661
A replication-selective herpes simplex virus type 1 ICP34.5 mutant (HSV-1716) has shown efficacy both in vitro and in vivo against human non-small cell lung cancer (NSCLC) cell lines but complete...
20.
Reynolds C, Mick R, Donohue J, Grant C, Farley D, Callans L, et al.
J Clin Oncol
. 1999 Nov;
17(6):1720-6.
PMID: 10561208
Purpose: Recent studies have suggested that the sentinel lymph node (SLN) biopsy is an accurate alternative staging procedure for women with breast cancer. The goal of this study was to...